Carl Zeiss Meditec AG AFX
XETR · Deutschland · Gesundheitstechnologie
€31,20-0,08 (-0,26 %)
Markt geschlossen· · EUR · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
Markt geschlossen· · EUR · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
Gesamtrendite inklusive Dividenden.
Wo der Kurs im Verhältnis zu seinen 50- und 200-Tage-Durchschnitten steht.
Makkler Fair Value, Finanzgesundheit, Analystenmeinung, Vergleichsunternehmen und MakklerAI.
ZEISS Medical Technology, one of the world's leading medical technology companies, announced expansive developments across its comprehensive ZEISS Retina Workflow at the European Society of Retina Specialists (EURETINA) congress, spanning retinal imaging, surgical visualization, digital workflow technologies and vitreoretinal surgery. The innovations further strengthen ZEISS's ability to support eye care professionals and retina specialists across the continuum of retinal care, from diagnosis an
Carl Zeiss Meditec has seen its share price fall sharply in recent years, which puts the spotlight firmly on whether the current valuation is still supported by its earnings. For anyone following the stock, the key issue now is how much of that setback is already reflected in what the market is willing to pay for each euro of profit. The share price has declined 80.6% over the past 5 years, which raises the question of how investors are now weighing the business against its earnings...
Carl Zeiss Meditec (XTRA:AFX) heads into the Berenberg and Goldman Sachs 15th German Corporate Conference on 23 September with investors watching how management frames recent share performance and underlying medical technology trends. Carl Zeiss Meditec’s share price has slipped over recent months, with a 30 day share price return of down 9.11% and a year to date share price return of down 25.49%. The 1 year total shareholder return of down 34.30% points to longer running pressure on...
Aktuelle Schlagzeilen Dritter zu diesem Unternehmen, getrennt von Makklers eigener Redaktion und mit Verlinkung zum Herausgeber. Für die Richtigkeit ist der jeweilige Herausgeber verantwortlich.